|
ZNF273 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.544600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.053600E-01 |
| Normal-vs-Stage2 |
1.007170E-01 |
| Normal-vs-Stage3 |
9.680600E-01 |
| Normal-vs-Stage4 |
5.264400E-01 |
| Stage1-vs-Stage2 |
1.368500E-02 |
| Stage1-vs-Stage3 |
2.827600E-01 |
| Stage1-vs-Stage4 |
7.355800E-02 |
| Stage2-vs-Stage3 |
7.792400E-02 |
| Stage2-vs-Stage4 |
2.372800E-01 |
| Stage3-vs-Stage4 |
4.537800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.744600E-01 |
| Normal-vs-AfricanAmerican |
6.987000E-01 |
| Normal-vs-Asian |
6.935600E-03 |
| Caucasian-vs-AfricanAmerican |
7.476600E-01 |
| Caucasian-vs-Asian |
3.840300E-03 |
| AfricanAmerican-vs-Asian |
2.039400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.597200E-01 |
| Normal-vs-Female |
4.259000E-01 |
| Male-vs-Female |
9.646300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.694370E-01 |
| Normal-vs-Age(41-60Yrs) |
9.722600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.628400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.263630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.536210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.140790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.820200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.322800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.029600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.261200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.169600E-01 |
| Normal-vs-Grade 2 |
8.558600E-01 |
| Normal-vs-Grade 3 |
4.896400E-01 |
| Normal-vs-Grade 4 |
2.977000E-01 |
| Grade 1-vs-Grade 2 |
8.446600E-01 |
| Grade 1-vs-Grade 3 |
6.320600E-01 |
| Grade 1-vs-Grade 4 |
6.369600E-01 |
| Grade 2-vs-Grade 3 |
4.978800E-01 |
| Grade 2-vs-Grade 4 |
1.711760E-01 |
| Grade 3-vs-Grade 4 |
7.626300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.193560E-01 |
| Normal-vs-ccB subtype |
1.107420E-01 |
| ccA subtype-vs-ccB subtype |
4.12290000000315E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.635800E-01 |
| Normal-vs-N1 |
1.257780E-01 |
| N0-vs-N1 |
1.488610E-01 |
|
|
